// App-Quantinova.ai

1256-182 : SECOND-GENERATION VERSUS FIRST-GENERATION DRUG-ELUTING STENTS IN PATIENTS WITH AND WITHOUT DIABETES MELLITUS: POOLED ANALYSIS FROM THE RESET AND NEXT TRIALS

Researchers

Presenter

  • Kenji Nakatsuma

Principal Investigators

  • Hiroki Shiomi

  • Masahiro Natsuaki

  • Takeshi Morimoto

  • Takeshi Kimura

Medical Centers

  • Kyoto University, Kyoto, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

  • Restenosis

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • sirolimus

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved